450 related articles for article (PubMed ID: 15028313)
1. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
2. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
3. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
4. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
[TBL] [Abstract][Full Text] [Related]
5. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
[TBL] [Abstract][Full Text] [Related]
6. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
7. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
8. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
9. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
Cornejo C; Portanova M
Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
13. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
14. Extended lymphadenectomy in gastric cancer: when, for whom and why.
Roukos DH
Ann R Coll Surg Engl; 1998 Jan; 80(1):16-24. PubMed ID: 9579122
[TBL] [Abstract][Full Text] [Related]
15. R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomised trial.
Bonenkamp JJ; van de Velde CJ; Sasako M; Hermans J
Eur J Surg; 1992 Aug; 158(8):413-8. PubMed ID: 1356480
[TBL] [Abstract][Full Text] [Related]
16. [Extensive lymph node dissection in stomach cancer? Initial results of the Dutch Stomach Cancer Study].
Bonenkamp JJ; Songun I; Hermans J; van de Velde CJ
Ned Tijdschr Geneeskd; 1996 May; 140(18):964-7. PubMed ID: 8692311
[TBL] [Abstract][Full Text] [Related]
17. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
Schmid A; Thybusch A; Kremer B; Henne-Bruns D
Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic gastrectomy for treatment of advanced gastric cancer: preliminary experience on 38 cases.
Allieta R; Nardi M; Brachet-Contul R; Millo P; Fabozzi M; Cornaglia S; Parini U
Minerva Chir; 2009 Oct; 64(5):445-56. PubMed ID: 19859035
[TBL] [Abstract][Full Text] [Related]
20. Extended lymph-node dissection for gastric cancer.
Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
